GTR Home > Tests > Search results - C0086651[DISCUI]

Apply filters

Showing tests for all 2697 conditions

Compare labs

Your search term can be found in tests with a total of 2697 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C0086651[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 33 tests for 2697 conditions in 17 labs

CCentoICU platinum

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Total conditions (769)
Total targets (514)

CCentoICU platinum plus

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Total conditions (769)
Total targets (514)

CMucopolysaccharidosis type IVA

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CGALNS. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CGALNS Sequence Analysis

Test targets
Methods
  • C Sequence analysis of the entire coding region

CMucopolysaccharidosis Type IVA / Morquio Type A Disease via the GALNS Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CCarrierMap

Lab: Recombine New York, New York, United States
Total conditions (299)
Total targets (297)

CMucopolysaccharidosis type 4A

Lab: Bioarray Elche, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CLysosomal Storage Disease Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (65)
Total targets (74)

CMucopolysaccharidosis IVA (sequence analysis of GALNS gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CPan-Ethnic Carrier Screen: Gene Sequencing Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (136)
Total targets (147)

CLysosomal Disorders Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (15)
Total targets (29)

CLysosomal Disorders Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (15)
Total targets (29)

ClysoSEEK™ Sequence Analysis for Lysosomal Storage Disorders

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (115)
Total targets (88)

CMetabolic Storage Disorders Panel Sequencing, 51 Genes

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (57)
Total targets (51)

CGALNS

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 33 tests for 2697 conditions in 17 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.